Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02573636 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 2022 to Nov 2026
    • Study completion date: Mar 2025 to Mar 2027
    • Site details revised at 9 of 9 sites
    v10
  2. Site contacts updated at 2 of 9 sitesv9
  3. Primary completion date: Jan 2030 to Jan 2022
    • Study completion date: Mar 2041 to Mar 2025
    • Site details revised at 4 of 9 sites
    v8
  4. Site contacts updated at 1 of 9 sitesv7
  5. Study sites: 10 to 9v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 12 to 10
    • Study completion date: Mar 2041
    v5
  2. Site details revised at 2 of 12 sitesv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 2016 to Mar 2016
    v3
  4. Study title expanded, about 13 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to evaluate the predictive value of TMPRSS2-ERG gene fusion and PTEN in patients with high risk prostate cancer treated with first line LHRH agonist after biochemical failure.
Trial Details
NCT Number NCT02573636
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov